立中集团(300428) - 2025 Q4 - 年度业绩

Financial Performance - Total revenue for 2025 reached CNY 3,213,917.13 million, an increase of 17.96% compared to CNY 2,724,636.68 million in the previous year[5] - Net profit attributable to shareholders was CNY 88,916.84 million, reflecting a growth of 25.75% from CNY 70,711.57 million year-on-year[5] - Basic earnings per share increased by 24.11% to CNY 1.39 from CNY 1.12 in the previous year[5] - The net profit after deducting non-recurring gains and losses grew by 30.77%, driven by the factors mentioned in the operational performance analysis[7] Asset and Equity Growth - The company's total assets increased by 11.69% to CNY 2,393,174.38 million from CNY 2,142,608.26 million at the beginning of the period[7] - The equity attributable to shareholders rose by 24.32% to CNY 901,447.38 million, up from CNY 725,090.82 million[7] - The weighted average return on equity increased to 11.44%, up from 10.15% in the previous year[5] Operational Highlights - The lithium hexafluorophosphate business turned profitable starting November, benefiting from market price recovery and increased capacity utilization[6] - The company focused on optimizing product structure and expanding into emerging markets, contributing to improved profitability[6] - The company continues to enhance its global supply capabilities with ongoing production in Thailand and Mexico, supporting revenue growth[6]